Clinical Microbiology
The Right Drug at the Right Dose
Bringing laboratory rigor to the bedside—translating cultures, sensitivity reports, and molecular tests into the precise clinical decision your patient needs.
- Diagnostic Stewardship: selecting and interpreting the most relevant tests—from Gram stains to PCR—to avoid over-testing.
- Antimicrobial Stewardship: correlating culture sensitivity with patient history for the right drug at the right dose.
- Molecular Diagnostics: advanced DNA/RNA-based testing for rapid, precise pathogen identification.
- Expert Interpretation: the bridge between raw lab numbers and actionable clinical bedside decisions.
Request interpretation support (+91) 9187207451
Frequently Asked
Common Questions
Most empiric prescribing can be tightened or de-escalated once cultures and sensitivities are available—reducing toxicity, cost, and the selective pressure that drives resistance. Stewardship reviews bring that interpretation to the bedside.
When time-to-diagnosis matters (sepsis, meningitis), when conventional cultures are likely to be negative (prior antibiotics, fastidious organisms), or when resistance markers change the regimen materially. PCR/NAAT panels are chosen, not reflexively ordered.
Yes—remote interpretation of reports, antibiogram review, and protocol design for sample collection and transport are offered. The goal is to make sure the clinical conclusion drawn from a report is as good as the report itself.